CC
SSAA

Covalis Capital’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Covalis Capital’s Portfolio SSAA Stock Details SSAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-70,000
Closed -$680K – 124
2021
Q3 		$680K Hold
70,000
– – 0.16% 63
2021
Q2 		$678K Buy
+70,000
New +$685K 0.22% 64

Other funds holding SSAA

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return

Covalis Capital's SSAA Position: Q4 2021 in Review

Covalis Capital sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q4 2021, closing a stake of 70,000 shares — an estimated $680K sold.

Covalis Capital first reported a position in SSAA in Q2 2021 and held it in 2 quarters. The position peaked at $680K in Q3 2021. 77 funds tracked by Wall St. Rank hold SSAA as of Q4 2021.

  • Covalis Capital reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q4 2021 after selling out during the quarter.
  • Covalis Capital sold 70,000 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q4 2021, an estimated $680K.
  • Covalis Capital first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q2 2021 and held it in 2 quarters.
  • Covalis Capital's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $680K in Q3 2021.
  • 77 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q4 2021.

Based on Covalis Capital's 13F filing for Q4 2021, filed 14 Feb 2022.